LIVE Price Database Suppliers B2B suppliers Quality & badges Encyclopedia Articles
LONGEVITY TOPICS
NAD+ Precursors Sirtuin Activators Senolytics Autophagy Mitochondrial Hormesis
About PeptideCompare Business Network Contact Policy
MONOGRAPH No. 117
TYPE
GnRH decapeptide
MW
1182.3 g/mol
CAS
33515-09-2
EU STATUS
Rx-only medicine + Research grade
WADA
Prohibited S2 (in males)
MIN PURITY
≥98% HPLC
Growth Hormone Axis

Gonadorelin — EU research guide.

Gonadorelin is the native gonadotropin-releasing hormone (GnRH) — a decapeptide used clinically for fertility testing and, in the research/biohacking community, to help maintain testicular function during testosterone therapy.

Last reviewed:

What is Gonadorelin?

Gonadorelin stimulates the pituitary to release LH and FSH, which in turn drive natural testosterone production and spermatogenesis. Pulsatile dosing mimics the body's own GnRH rhythm; continuous dosing instead desensitises the pituitary — the opposite effect, used deliberately by long-acting GnRH agonist drugs.

Clinical and research use

Clinically, gonadorelin is used for diagnostic pituitary-function testing and, off-label, alongside exogenous testosterone to help preserve fertility and testicular size — the same rationale behind hCG use, though gonadorelin acts one step higher in the hypothalamic-pituitary-gonadal axis.

EU legal status

Approved as a prescription medicine in several EU countries for diagnostic use; also available as a research-grade peptide. WADA prohibits GnRH and its agonists for male athletes (S2), since they can raise endogenous testosterone.

⚠ Prescription-only medicine in most EU countries; WADA-prohibited for male athletes. Short half-life requires frequent or pulsatile dosing to be effective.
✓ For the related HPG-axis compound used in similar protocols, PeptideCompare tracks hCG from EU research vendors with COA documentation.

Molecular information

Molecular formula
C55H75N17O13
Molecular weight
1182.3 g/mol
CAS number
33515-09-2

Pharmacokinetics

Route
Intravenous
Half-life (t½)
≈ 2–8 min
Source: Handelsman & Swerdloff, Endocr Rev 1986; FDA NDA 017866 — curve modelled on the midpoint of the published range

HPG-axis compounds across EU suppliers

COA-verified EU vendors · Updated monthly

Frequently asked questions

What is Gonadorelin? ▾

Gonadorelin is a GnRH decapeptide that stimulates the pituitary to release LH and FSH, which in turn drive natural testosterone production and spermatogenesis.

Why does the dosing pattern matter for Gonadorelin? ▾

Pulsatile dosing mimics the body's own GnRH rhythm, whereas continuous dosing desensitises the pituitary, the opposite effect, which is used deliberately by long-acting GnRH agonist drugs.

How is Gonadorelin used clinically? ▾

It is used for diagnostic pituitary-function testing and, off-label, alongside exogenous testosterone to help preserve fertility and testicular size.

How does Gonadorelin differ from HCG? ▾

Both aim to preserve fertility and testicular size, but gonadorelin acts one step higher in the hypothalamic-pituitary-gonadal axis by stimulating the pituitary rather than the testes directly.

Is Gonadorelin legal in the EU? ▾

It is approved as a prescription medicine in several EU countries for diagnostic use and is also available as a research-grade peptide.

Is Gonadorelin banned in sport? ▾

Yes. WADA prohibits GnRH and its analogs in males (S2).

Related guides

PeptideCompare AssistantOnline · replies instantly
Hi! I help you quickly find the right page — about legality, COAs, badges or suppliers. No price advice, no dosing.
Try a question
Find a supplier Questions about a peptide? Read our articles Compare prices Is this legal in the EU? How to read a COA What do badges mean? Will customs stop my order? What is BAC water? Talk to a doctor first?
Navigation assistant · no medical advice